Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06824259

The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer

The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Diagnostic Decision-making in Patients With Suspected Prostate cancer--a Single-center Prospective Randomized Controlled Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Peking University First Hospital · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to investigate the value of dual-parameter magnetic resonance imaging(bpMRI) combined with regional saturation biopsy in the diagnosis of prostate cancer by means of a prospective randomized controlled study. The main questions it aims to answer are: Can bpMRI guide the timing of prostate puncture and avoid unnecessary prostate biopsy? Effectiveness of focal saturation biopsy versus systemic biopsy + targeted biopsy.

Conditions

Interventions

TypeNameDescription
PROCEDUREFollow up if MRI is negativeEnter the follow-up cohort without systematic biopsy when prostate cancer is clinically suspected and no PIRADS v2.1 score ≥3 lesions are detected on initial examination. MR plus regional saturation biopsy was performed when MRI progressed.
PROCEDURESystematic biopsy if MRI is negativeSystematic biopsy was performed if there was clinical suspicion of prostate cancer and no PIRADS v2.1 score ≥3 lesions were detected on initial examination. If the biopsy was negative enter the follow-up cohort.

Timeline

Start date
2025-05-14
Primary completion
2027-12-31
Completion
2029-06-30
First posted
2025-02-13
Last updated
2025-08-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06824259. Inclusion in this directory is not an endorsement.